Skip to main content
. 2020 Feb 29;4(1):95–99. doi: 10.1016/j.jseint.2019.11.007

Table I.

Characteristics of total shoulder replacement by sex, 2012-2016

Total, n (%)
(N = 12,530)
Female, n (%)
(n = 6946)
Male, n (%)
(n = 5499)
P value
Age group, y <.001
 18-49 356 (2.9) 130 (1.9) 226 (4.1)
 50-59 1543 (12.4) 665 (9.6) 878 (16)
 60-69 4309 (34.6) 2305 (33.2) 2004 (36.4)
 ≥70 6237 (50.1) 3846 (55.4) 2391 (43.5)
BMI group <.001
 <18.5 (underweight) 81 (0.7) 66 (1) 15 (0.3)
 18.5-24 1920 (15.5) 1271 (18.4) 649 (11.8)
 25-29 4001 (32.3) 1964 (28.4) 2037 (37.1)
 30-34 3290 (26.5) 1654 (23.9) 1636 (29.8)
 ≥35 3108 (25.1) 1961 (28.4) 1147 (20.9)
Functional status <.001
 Independent 12,049 (97.5) 6671 (96.6) 5378 (98.5)
 Dependent 313 (2.5) 232 (3.4) 81 (1.5)
ASA score <.001
 1-2 5702 (45.9) 3060 (44.1) 2642 (48.1)
 ≥3 6729 (54.1) 3881 (55.9) 2848 (51.9)
Hypertension 8299 (66.7) 4669 (67.2) 3630 (66) .162
Diabetes 2179 (17.5) 1174 (16.9) 1005 (18.3) .048
Smoker 1348 (10.8) 689 (9.9) 659 (12) <.001
History of COPD 828 (6.7) 524 (7.5) 304 (5.5) <.001
History of Dyspnea 793 (6.4) 528 (7.6) 265 (4.8) <.001
History of CHF 61 (0.5) 35 (0.5) 26 (0.5) .907
Dialysis 54 (0.4) 22 (0.3) 32 (0.6) .036
Steroid use 619 (5) 424 (6.1) 195 (3.5) <.001
Bleeding disorder 334 (2.7) 156 (2.2) 178 (3.2) <.001

BMI, body mass index; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure.